Astec LifeSciences Limited — Board Meeting, 28-07-2025: Outcome of Board Meeting

Astec LifeSciences' board has announced a meeting outcome, approving its consolidated financial results for the quarter ended June 30, 2025. Revenue from operations stood at Rs. 91.08 Cr, with a net loss of Rs. 33.04 Cr. The company is actively conducting its Rights Issue, offering up to 28,01,673 shares for Rs. 249.35 Cr at Rs. 890 per share. This capital raise, on a 1:7 ratio, closes today, July 28, aiming to boost the company's financial strength.